We are live on
!
Find out more
AEGR
Aegerion Pharmaceuticals
AEGR
AEGR
Delisted
AEGR was delisted on the 29th of November, 2016.
0 hedge funds and large institutions have $0 invested in Aegerion Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% less funds holding
Funds holding: 58 → 0 (-58)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $84.5M → $0 (-$84.5M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 58
Holders
–
Holders Change
-58
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
58
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
SCM
Scopia Capital Management
New York
|
-$16.9M |
| 2 |
BC
Broadfin Capital
New York
|
-$13M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.52M |
| 4 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
-$7.87M |
| 5 |
Renaissance Technologies
New York
|
-$5.1M |
